Schedule 13G ownership disclosure

Silence Therapeutics plc

Security class unavailable · CUSIP: G8128Y157

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-24-000084
Form type
SC 13G/A
Filer
Lombard Odier Asset Management (USA) Corp
CIK
CIK 1491719
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub